1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Abbott Laboratories

Abbott Laboratories

ABT
Abbott LaboratoriesUS flagNew York Stock Exchange
90.53
USD
+2.70
- -
157.69BMarket Cap

Total Valuation

Abbott Laboratories carries a market capitalization of 157.69B, placing it among publicly traded companies globally. Its enterprise value stands at 205.98B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap157.69B
Enterprise Value205.98B

Share Statistics

Abbott Laboratories currently has 1.74B shares outstanding.

Shares Outstanding1.74B
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Abbott Laboratories trades at a trailing price-to-earnings ratio of 28.46. The price-to-sales ratio is 3.96, and the price-to-book ratio stands at 2.37.

PE Ratio28.46
PS Ratio3.96
PB Ratio2.37
P/TBV Ratio-452.12
P/FCF Ratio15.54
P/OCF Ratio18.87

Enterprise Valuation

On an enterprise value basis, Abbott Laboratories trades at an EV/EBITDA multiple of 18.95 and an EV/FCF ratio of 17.22. The EV/Sales ratio of 4.56 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 26.73 provides insight into valuation relative to core operating earnings.

EV / Sales4.56
EV / EBITDA18.95
EV / EBIT26.73
EV / FCF17.22

Financial Position

Abbott Laboratories maintains a current ratio of 1.39, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 64.60, indicating elevated leverage, while an interest coverage ratio of 20.28 demonstrates strong ability to service its debt obligations.

Current Ratio1.39
Quick Ratio1.01
Debt / Equity64.60
Debt / EBITDA3.13
Interest Coverage20.28

Financial Efficiency

Abbott Laboratories posts a return on equity of 8.47 and a return on invested capital of 7.97.

Return on Equity (ROE)8.47
Return on Assets (ROA)6.54
Return on Invested Capital (ROIC)7.97
Return on Capital Employed (ROCE)6.81
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.90

Taxes

Over the trailing twelve months, Abbott Laboratories has paid 1.86B in income taxes, reflecting an effective tax rate of 22.87.

Income Tax1.86B
Effective Tax Rate22.87

Stock Price Statistics

Abbott Laboratories's stock has declined approximately -32.06514% over the past 52 weeks. The 50-day moving average sits at 89.83, while the 200-day moving average is 113.41.

Beta (5Y)N/A
52-Week Price Change-32.06514%
50-Day Moving Average89.83
200-Day Moving Average113.41
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Abbott Laboratories generated 45.13B in revenue and converted that into 6.28B in net income, yielding earnings per share of 3.59. EBITDA reached 10.87B, while operating income came in at 7.71B.

Revenue45.13B
Gross Profit25.39B
Operating Income7.71B
Pretax Income8.14B
Net Income6.28B
EBITDA10.87B
EBIT7.71B
Earnings Per Share (EPS)3.59

Balance Sheet

Abbott Laboratories holds 7.30B in cash and equivalents against 34.05B in total debt, resulting in a net debt position of 27.24B. Total book value stands at 75.31B, with working capital of 7.13B providing operational flexibility.

Cash & Cash Equivalents7.30B
Total Debt34.05B
Net Debt27.24B
Equity (Book Value)75.31B
Book Value Per Share43.29
Working Capital7.13B

Cash Flow

Abbott Laboratories produced 9.46B in operating cash flow over the past twelve months. After subtracting -2.09B in capital expenditures, free cash flow totaled 7.38B - equivalent to 4.24 per share.

Operating Cash Flow9.46B
Capital Expenditures-2.09B
Free Cash Flow7.38B
FCF Per Share4.24

Margins

Abbott Laboratories operates with a gross margin of 56.26, reflecting its pricing power and cost economics. The operating margin of 17.07 and net profit margin of 13.91 provide insight into operational efficiency.

Gross Margin56.26
Operating Margin17.07
Pretax Margin18.03
Profit Margin13.91
EBITDA Margin24.08

Dividends & Yields

The company's payout ratio of 66.73 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share2.41
Dividend YieldN/A
Payout Ratio66.73
Shareholder Yield-7.31
FCF Yield6.43

Stock Splits

Abbott Laboratories's most recent stock split took place on January 2, 2013 with a 2399:5000 split ratio.

Last Split Date1/2/2013
Split Ratio2399:5000

Scores

Abbott Laboratories posts an Altman Z-Score of 4.46, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.46